Venture capital fund · 1 deal
$20 million VC fund
Every published round Bupa Ventures took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Vively | Seed | 28 May 2025 | $1.6m | Participant | SmartCompany, Startup Daily, Forbes Australia |
Companies Bupa Ventures has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Vively | Metabolic health monitoring platform combining real-time glucose monitoring with AI-drive… | 28 May 2025, Seed | 1 | 0 |
Fund closes reported for Bupa Ventures, as distinct from the investments it has made.
Companies Bupa Ventures has backed that another company then bought. An exit for the holding, not a deal Bupa Ventures did.
Stories naming Bupa Ventures. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Vively, founded by triathlete Tim Veron after reversing his pre-diabetes, raised $1.6 million seed funding led by Archangel Ventures with Bupa Ventures, and has partnered with Bupa to make continuous glucose monitoring more affordable.
Australian startups Diraq, Marqo, and Hatch secured funding rounds. Ansarada was acquired by Datasite. Bupa launched a new venture fund, and the Queensland government backed several VCs and accelerators.
Health insurer Bupa has rolled out a $20 million corporate venture vehicle, Bupa Ventures, for early-stage health startups in Australia; the article also recalls Cassava Bags winning Bupa's eco-Disruptive prize and equity crowdfunding.